II. New perspectives and challenges in the understanding of mantle cell lymphoma

Annals of Oncology

Volumn 22, Issue , 2011, Pages iv32-iv35

  Navarro, A ^a   Campo, E ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85081611093     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr168     Document Type: Conference Paper

References (20)

1. Jares, P., Colomer, D., Campo, E., Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 7 (2007), 750–762.
2. Wiestner, A., Tehrani, M., Chiorazzi, M., et al. Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood 109 (2007), 4599–4606.
3. Jiang, Q., Feng, M.G., Mo, Y.Y., Systematic validation of predicted microRNAs for cyclin D1. BMC Cancer, 9, 2009, 194.
4. Bea, S., Salaverria, I., Armengol, L., et al. Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling. Blood 113 (2009), 3059–3069.
5. Tiemann, M., Schrader, C., Klapper, W., et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol 131 (2005), 29–38.
6. Fu, K., Weisenburger, D.D., Greiner, T.C., et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 106 (2005), 4315–4321.
7. Salaverria, I., Zettl, A., Bea, S., et al. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. J Clin Oncol 25 (2007), 1216–1222.
8. Quintanilla-Martinez, L., Slotta-Huspenina, J., Koch, I., et al. Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR. Haematologica 94 (2009), 1595–1598.
9. Ek, S., Dictor, M., Jerkeman, M., et al. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood 111 (2008), 800–805.
10. Mozos, A., Royo, C., Hartmann, E., et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica 94 (2009), 1555–1562.
11. Dictor, M., Ek, S., Sundberg, M., et al. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Haematologica 94 (2009), 1563–1568.
12. Dono, M., Cerruti, G., Zupo, S., The CD5+ B-cell. Int J Biochem Cell Biol 36 (2004), 2105–2111.
13. Hadzidimitriou, A., Agathagelidis, A., Murray, F., et al. Sequence-based evidence for antigen selection in mantle cell lymphoma: remarkable immunoglobulin gene repertoire biases, stereotyped antigen-binding sites and recurrent hypermutations in certain subsets. 2009 ASH Annual Meeting Abstracts. Blood, 114(22), 2009 Abstract 1933.
14. Murray, F., Darzentas, N., Hadzidimitriou, A., et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 111 (2008), 1524–1533.
15. Orchard, J., Garand, R., Davis, Z., et al. A subset of t(11; 14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 101 (2003), 4975–4981.
16. Kolar, G.R., Mehta, D., Pelayo, R., et al. A novel human B cell subpopulation representing the initial germinal center population to express AID. Blood 109 (2007), 2545–2552.
17. Martin, P., Chadburn, A., Christos, P., et al. Outcome of deferred initial therapy in mantle-cell lymphoma. J Clin Oncol 27 (2009), 1209–1213.
18. Angelopoulou, M.K., Siakantariz, M.P., Vassilakopoulos, T.P., et al. The splenic form of mantle cell lymphoma. Eur J Haematol 68 (2002), 12–21.
19. Fernandez, V., Salamero, O., Espinet, B., et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res 70 (2010), 1408–1418.
20. Wang, X., Asplund, A.C., Porwit, A., et al. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br J Haematol 143 (2008), 248–252.